期刊文献+

宫颈TCT检查结果为ASCUS患者HPV检测的意义研究 被引量:2

下载PDF
导出
摘要 目的:对宫颈薄层液基细胞学检查结果为不典型鳞状上皮细胞(ASC-US)的患者,通过高危型人乳头瘤病毒(HPV)DNA检测进行临床分流管理。方法:对662例ASC-US患者进行高危型HPV-DNA检测及宫颈活检病理学检查。结果:高危型HPV-DNA检测结果阳性为215例,阳性率为32.48%。病理结果为慢性宫颈炎、宫颈上皮内瘤样病变(CIN)Ⅰ、CINⅡ、CINⅢ和宫颈浸润癌的患者高危型HPV病毒阳性所占比例为17.10%、57.33%、78.85%、93.10%、100%。结论:高危型HPV阳性预示着可能有宫颈高度癌前期病变的存在,或有可能发展为宫颈高度癌前期病变,HPV阴性则意味着几乎不会发生宫颈癌,及时合理地检测高危型HPV对宫颈病变的临床处理起着科学分流管理的作用。
作者 申艳 阚延静
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第1期120-121,共2页 Journal of Nanjing Medical University(Natural Sciences)
  • 相关文献

参考文献6

  • 1Kuhn L, Denny L, Pollack A, et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings [ J ]. Natl Cancer Inst, 2000,92 (2) : 818-822
  • 2冯燕,王新宇,程易凡,程晓东,吕卫国,谢幸.高危型HPV负荷量与宫颈癌及其前期病变关系的研究[J].现代妇产科进展,2008,17(10):730-732. 被引量:18
  • 3Nobbenhuis MA,Walboomers JM,Hemerhorst TJ,et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening:a prospective study[J]. Lancet, 1999,354(9172) :20-25
  • 4Kiatpongsan S, Niruthisard S, Mutirangura A, et al.Role of human papillomavirus DNA testing in man agement of women with atypical squamous cells of undetermined significance[J]. Int J Gynecol Cancer, 2006,16( 1 ) :262-265
  • 5Andersson S,Safari H, Mints M.Type distribution,viral load and integration stsaus of high-risk human papillomavirus in prestages of cervical cancer[J]. Br J Cancer, 2005,92(12) :2195-2200
  • 6赵方辉,李楠,马俊飞,张洵,吴令英,戎寿德,Lorincz A,Belinson J,乔友林.山西省襄垣县妇女人乳头状瘤病毒感染与宫颈癌关系的研究[J].中华流行病学杂志,2001,22(5):375-378. 被引量:209

二级参考文献15

  • 1李洁,刘宝印,zur Hausen H,王宏,杨学志,李力,刘文,刘洪隐,陆克昭,刘旭,牛春燕,裴润芳,苏钟浦,王言贵,董继华,张桂宁,刘春杰,许吉林,林毓纯.中国妇女宫颈癌组织中人乳头瘤病毒感染及其地理分布的调查[J].中华实验和临床病毒学杂志,1996,10(1):50-55. 被引量:67
  • 2De Francesco MA, Gargiulo F, Schreiber C, et al. Detection and genotyping of human papillomavirus in cervical sampies from Italian patients [ J ]. J Med Virol, 2005,75 : 588- 592
  • 3Cox JT. Human papillomavirus testing in primary cervical screening and abnormal papanicolaou management [ J ]. Obstet Gynecol Surv,2006,61 :S15-25
  • 4Ordi J, Alonso I, Tome A, et al. Human papillomavirus load in Hybrid Capture Ⅱ assat:does increasing the cutoff improve the test? [ J] Gynecol Oncol,2005 ,99 :313-319
  • 5Wu Y, Chen Y, Li L, et al. Associations of high-risk HPV types and viral load with cervical cancer in China [ J ]. J Clin Virol,2006,35:264-269
  • 6Oddi J, Puig-Tintore LM, Tome A, et al. Contribution of high risk human papillomavirus testing to the management of premalignant and malignant lesions of the uterine cervix [J]. Med J Clin,2003,121:441-445
  • 7Riethmuller D, Gay C, Bertrand X, et al. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture Ⅱ and polymerase chain reaction [ J ]. Di- agn Mol Pathol, 1999 ;8 : 157-164
  • 8Lin HP, Huang YY, Wu HY, et al. Method for testing for human papillomavirus infection in patients with cervical intraepithelial disease [ J ]. J Clin Microbiol, 2004,42 : 366- 368
  • 9Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus : the HART study [ J 1. Lancet,2003,362 : 1871- 1876
  • 10Guyot A, Karim S, Kyi MS, et al. Evaluation of adjunctive HPV testing by Hybrid Capture Ⅱ in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy [ J ]. BMC Infect Dis, 2003,3:23

共引文献225

同被引文献23

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部